Home > Browse Research > Life Sciences > Pharmaceuticals > Vaccines > Cancer Vaccines

Cancer Vaccines: market research reports

Once a theoretical concept, there are now some therapies on the market. Lung Cancer, cervical cancer, prostate cancer and melanoma represent conditions where vaccines have shown effectiveness. However, this area of medicine is a new frontier and many of the issues that face the cancer vaccine market are novel. However, this is a very promising area of medicine, which will continue to assist in the fight against cancer.

The cancer vaccine industry has a promising future by all indications propelled by advances in molecular biology technology. The industry is poised for unprecedented growth and market participants face countless opportunities if they are equipped with a strategic plan of action. However, there are numerous stumbling blocks along the way that can interfere with advancement of cancer vaccines. One of the major interests is in early detection and screening for cancer. Education and advancement of methods to detect cancer early are paramount. Another issue that affects the introduction of new vaccine products is reimbursement. Controversial issues face some of the products that have been approved or are in late stage development. Manufacturers must demonstrate that the new vaccine is superior to other products on the market. New technology and innovations regarding the treatment of cancer face the same challenge as far as demonstrating that pharmacogenomics and personalized medicine is worth the anticipated additional cost.

Cancer Vaccines market research reports and industry analysis

Global Vaccine Market Forecast to 2017 5/1/2013 \| published by: RNCOS ... a scenario, vaccines, which have high entry barriers for generic players and the potential to generate blockbuster sales, are increasingly alluring the players. Besides, the market has also gained momentum due to the recent technological ... \| read more...	$1,500.00
Cancer Vaccines Drug Pipeline Update 2013 4/22/2013 \| published by: BioSeeker Group AB ... elusive, leaving the market wide open. There are today 223 companies plus partners developing 255 cancer vaccine drugs in 538 developmental projects in cancer. In addition, there are 7 suspended drugs and the accumulated number ... \| read more...	$5,621.25
Analytical Tool - Cancer Vaccines 4/22/2013 \| published by: BioSeeker Group AB ... the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their ... \| read more...	$11,625.00
Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake 3/31/2013 \| published by: GBI Research ... “Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake”. There is currently only one marketed therapeutic cancer vaccine, Provenge, which is indicated for ... \| read more...	$3,500.00
Cancer Vaccines: From First-in-Class to Best-in-Class? 3/19/2013 \| published by: BioSeeker Group AB ... and companies are setting the path? What is first-in-class in the cancer vaccine pipeline? Is First-in-Class the Best-in-Class? Indication expansion opportunities Drug repositioning opportunities Which pathways are targeted, by what and how? Locate the right ... \| read more...	$2,925.00
Triple Analysis: Angiogenesis, Cancer Vaccines and Protein Kinase Inhibitors 3/19/2013 \| published by: BioSeeker Group AB ... pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. Below is ... \| read more...	$5,175.00
Triple Analysis: Apoptosis, Cancer Vaccines and Peptides 3/19/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Cancer Vaccines and Protein Kinase Inhibitors 3/19/2013 \| published by: BioSeeker Group AB ... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Leukemia and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Lymphoma and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Breast Cancer, Prostate Cancer and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Colorectal Cancer, Angiogenesis and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Colorectal Cancer, Apoptosis and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Colorectal Cancer, Cancer Vaccines and Antibodies 3/19/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| read more...	$5,175.00
Triple Analysis: Colorectal Cancer, Cancer Vaccines and Peptides 3/19/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| read more...	$5,175.00
Triple Analysis: Colorectal Cancer, Lymphoma and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Colorectal Cancer, Melanoma and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Leukemia, Cancer Vaccines and Antibodies 3/19/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Leukemia, Lymphoma and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. ... \| read more...	$5,175.00
Triple Analysis: Leukemia, Melanoma and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. ... \| read more...	$5,175.00
Triple Analysis: Lung Cancer, Apoptosis and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Lung Cancer, Cancer Vaccines and Antibodies 3/19/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| read more...	$5,175.00
Triple Analysis: Lung Cancer, Cancer Vaccines and Protein Kinase Inhibitors 3/19/2013 \| published by: BioSeeker Group AB ... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ... \| read more...	$5,175.00
Triple Analysis: Lung Cancer, Pancreatic Cancer and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00
Triple Analysis: Lung Cancer, Prostate Cancer and Cancer Vaccines 3/19/2013 \| published by: BioSeeker Group AB ... in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between ... \| read more...	$5,175.00

< prev 1 2 3 4 5 6 7 next >